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Accepted 1 February 2018; Published online 10 February 2018AbstractObjectives: To develop a guideline on Responsible Epidemiologic Research Practice that will increase value and transparency, increase
the accountability of the epidemiologists, and reduce research waste.
Setting: A working group of the Netherland Epidemiological Society was given the task of developing a guideline that would meet
these objectives. Several publications about the need to prevent Detrimental Research Practices triggered this work. Among these were
a series in the Lancet on research waste and a subsequent series on transparency in the Journal of Clinical Epidemiology. The reputation
and trust in epidemiologic research is still high, and the Netherlands Epidemiological Society wishes to keep it that way. The guideline
deals with how epidemiologic research should be conducted, archived, and disclosed. It does not deal with the more technical aspects, such
as required sample size, choice of study design, and so forth. The guideline describes each step in the process of conducting an epidemi-
ologic study, from the first idea to the ultimate publication and beyond.
Methods: The working group reviewed the literature on responsible research conduct, including the various existing codes of conduct.
It applied the general principles from these codes to the elements of an epidemiologic study and formulated specific recommendations for
each of these. Next step was to draft the guideline. Preceding the 2016 annual national epidemiology conference in Wageningen, a precon-
ference was organized to discuss the draft guideline and to assess support. Support was clearly present, and the provided recommendations
were incorporated into the draft guideline. In March 2017, a draft version of the guideline was sent to all 1,100 members of the society with
the request to review and provide comments. All received responses were positive, and some minor additions were made. The Responsible
Epidemiologic Research Practice guideline has now been approved by the board of the Netherlands Epidemiological Society.
Conclusion: With the Responsible Epidemiologic Research Practice guideline, we hope to contribute to better research practices in
epidemiology but perhaps also in adjacent disciplines.  2018 The Authors. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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There is ample evidence that scientific research practices
are not sound and that study results are not as reproducible
as they should be [1e3]. Evidence indicates that detrimental
researchpractices in fact are quite common[4e8].Detrimental
research practices are often of a methodological nature and
may for instance concern selective reporting of research find-
ings, not reporting the results of a scientific study, protocoless article under the CC BY-NC-ND license (http://creativecommons.org/
inical Epidemiology 100 (2018) 111e119What is new?
Key findings
 We present a guideline on how epidemiologic
research can be conducted in a responsible manner.
The guideline will increase transparency and
accountability and will reduce research waste.
 The Netherlands Epidemiological Society has
developed a guideline to enhance responsible
epidemiologic research practice.
What this adds to what was known?
 Following the Responsible Epidemiologic
Research Practice will reduce detrimental research
practices and will increase transparency and
accountability.
What is the implication and what should change
now?
 Following the guideline will increase the reliability
and transparency of future epidemiologic research.
112 G.M.H. Swaen et al. / Journal of Cldeviations not clearly described in the publication, data
dredging, and presenting a study as being of hypothesis
testing nature although it was set up as an explorative
endeavor. A number of cases of research fraud and miscon-
duct served as a wake-up call for the scientific community
[5,9,10]. In a meta-analysis of 21 surveys, Fanelli [5] re-
ported that 33% of the scientists admitted to having been
involved in detrimental research practices and 2% in
research misconduct at least once in the last 3 years.
Research integrity is a topic that is receiving more and
more attention [11,12]. Concerns about research miscon-
duct such as fabrication and falsification of data and detri-
mental research practices have triggered the establishment
of several codes of research conduct, including for
example, the Netherlands Code of Conduct for Scientific
Practice [13], the European Code of Conduct for Research
Integrity [14], and the Singapore Statement on Research
Integrity [15]. Furthermore, the US National Academy of
Sciences has published a report on how it expects scientists
to operate [4].
Concerns about detrimental research practices and
research misconduct clearly also apply to biomedical
research and by extension to epidemiologic research. A
few years ago, a series of articles in the January 2014 issue
of the Lancet voiced concern about how biomedical
research is conducted and proposed measures to improve
research practice. In the associated commentary, Kleinert
and Horton [16] recommended researchers to reconsider
how they conduct their studies and how they can contribute
to reliable and accessible evidence that addresses thechallenges faced by society. In their Reducing Waste and
Reward Diligence statement of 2014, also published in
the Lancet, the research waste campaign has set a number
of objectives to maximize our research potential (http://
www.thelancet.com/campaigns/efficiency). In 2009, Glas-
ziou and Chalmers [17] estimated that 85% of today’s clin-
ical research may be wasted, not contributing to the
advancement of science. In a more recent (2016) series of
articles in the Journal of Clinical Epidemiology, the need
for more transparency and accountability in biomedical
research was further emphasized [18,19].
Concern about detrimental research practices in epide-
miology is not new. In 1988, the late Alvan Feinstein
[20] already described how fraud and deception cause
prominent problems in medical research. In 1991, a report
on Good Epidemiological Practice was published,
providing guidelines on how epidemiologic research in
occupational and environmental epidemiology should be
conducted [21]. This report already contained elements of
responsible epidemiological research practices. Concern
about selective reporting or outcome reporting bias has
been substantial in the field of clinical trials, where most
evidence on the occurrence of the detrimental research
practices has been generated. Currently, preregistration of
trials, for example, at the US Government trials register
is quite common but still not universally accepted [8].
The All Trials initiative has played a key role in getting pre-
registration anchored into the legislative framework of the
United Kingdom [22].
Epidemiologic research has had and is likely to continue
to have an important role in evidence-based public health
and clinical medicine. Epidemiologic research findings have
greatly contributed to improving human health by identifying
risk factors, evaluating preventive programs, determining the
best treatments for disease and care, and providing insight
into prognostic factors. Given the limited resources available,
it is of great importance that biomedical research is carried
out according to the best feasible scientific standards. Epide-
miology studies cannot be done without the participation of
patients or healthy volunteers who invest their time and
participate in studies they believe are performed according
to the highest feasible standards. Scientists have a responsi-
bility toward these human subjects to collect, analyze, and
report these data, following responsible research practices.
Although much has already been achieved in the form of
the codes mentioned previously, trials registration and other
reporting guidelines (see Equator website: www.equator-
network.org), much work still needs to be done.
Epidemiologists often are perceived and also see them-
selves as the sentinels of the methods for clinical and public
health research. They often participate in multidisciplinary
studies because of their valued knowledge and skills with
respect to research methodology. Therefore, they often
are in a good position to promote responsible research prac-
tices far beyond their own discipline and have the oppo-
rtunity to set an example for other research fields as well.
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logical Society to set up the working group Responsible
Epidemiologic Research Practice to address this issue.
The working group has developed a guideline about how
epidemiologic research should be conducted to increase
value and reduce waste in epidemiologic research and in-
crease transparency and accountability. The guideline does
not deal with the contents of epidemiology studies, such as
the proper sample size, study design, or measuring tools,
but it focusses on the process. The guideline applies to all
sorts of epidemiology studies and does not provide guid-
ance on specific methodological issues.
The Netherlands Epidemiological Society has a 30-year
track record of activities to increase the value of epidemio-
logic research and training, including the certification of
epidemiologists at MSc and PhD level. The reputation of
Dutch epidemiologists and of scientists in general is still
high, and the Netherlands Epidemiological Society is keen
on maintaining this. The society therefore encourages its
members and other epidemiologists to inform themselves
of this document and follow its recommendations. So far,
the Dutch epidemiologic research community has remained
relatively free of fraud cases, but a few of these may ruin
this high standing reputation. More importantly, epidemio-
logic research should meet high-quality standards, be repro-
ducible, and always be relevant to society.2. Methods
In their 5-year strategic plan for 2016e2020, the
Netherlands Epidemiological Society labeled improving
the quality of epidemiologic research as one of its key ob-
jectives. The Responsible Epidemiologic Research Practice
(RERP) working group reviewed recent publications such
as the earlier mentioned series in the Lancet on research
waste and Responsible Research Practice. The working
group held several face-to-face meetings to review various
draft proposals for the guideline. In constructing the guide-
line, it essentially followed the evidence-based methodol-
ogy to develop guidelines, the Evidence-Based Guideline
Development method [23]. As recommended by this
method, the working group consulted epidemiologists to
obtain their input and to assess their support for the guide-
line. The working group conducted a systematic review of
the literature, but this did not yield any evidence, in support
or against, that a guideline to enhance responsible research
practice or components thereof would be effective. A draft
guideline proposal was circulated among the approximately
1,100 members of the Netherlands Epidemiological Soci-
ety, and they were invited to provide comments. A precon-
ference to the 2016 annual Dutch conference of the
Netherlands Epidemiological Society was organized in
which the guideline proposal was discussed and later
amended. The final draft was sent to all its members with
the request for final commenting in March 2017.3. Results: the guideline on Responsible Epidemiologic
Research Practice
As stated earlier, several national and international institu-
tions in the scientific community have published codes of
conduct for researchers [13e15]. These codes of conduct
are aspirational in the sense that they focus on virtues and
values and provide general guidance for the way scientific
research should be conducted. Most codes prescribe that sci-
entists should be reliable, impartial, independent, honest,
objective, and open. These principles need to be translated
into concrete behavior and expressed in terms of do’s and
don’ts. By applying the general principles laid down in these
codes of conduct to the entire sequence of an epidemiologic
study, the working group developed the guideline.
As in many types of other research, in a typical epidemio-
logic study, three phases can be identified. First, the studymust
be prepared. Second, the study is conducted or executed, and
third, the study findings are published, and the study is
archived. This boils down to the following sequence:
1. Preparation of the study
a. Setting up the study group
b. Constructing a meaningful research question
c. Designing a study protocol/grant proposal
d. Submitting a grant proposal and obtaining financial
support
e. Ethical review
2. Conducting the study




3. Dissemination and aftercare
a. Manuscript submission and reporting
b. Contact with journalists
c. Data archiving and sharing
d. Document archiving
e. Accountability and transparency
The guideline applies to all of these elements and beyond.
The level of detail in documents to be archived should be
such that a knowledgeable scientist can reconstruct how
the study was conducted and why certain decisions were
made. The more details provided the more transparency is
achieved and the better accountable the researchers are.
We will now describe in general terms how to do so,
following the general sequence of any epidemiologic study.
4. Study preparation
4.1. Setting up the study group
The first step in any epidemiologic study is establishing
the study group. Scientific research is preferably not
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tists work together to collectively design, conduct, and
report the study. Study groups as a rule are more self-
corrective than researchers working by themselves.
The study group should contain sufficient expertise to be
able to reliably carry out the entire study throughout all its
phases and aspects. Members of the study group should be
sufficiently trained to fulfill the tasks they will be respon-
sible for. Each member should be aware of what he/she is
expected to contribute and what tasks must be performed.
It is strongly recommended that at this stage author lists
are made for the envisioned publications. To avoid
disagreement at a later stage, it is recommended to also
determine the envisioned order of authors, together with
their responsibilities. Authors should only be listed, if they
fulfill the relevant criteria for authorship as for example
described by the International Committee of Medical Jour-
nal Editors [24]. Conversely, authors who do not perform
the tasks as agreed should be removed from the author list.
This should be evaluated before manuscript submission.
Also, potential conflicts of interest and financial aspects
should be discussed within the study group at this stage
and the way these will be handled.4.2. Constructing a meaningful and relevant research
question
Any sound and reliable scientific study needs to be care-
fully designed and planned. The first task of the study
group is to define the aim of the study or the specific hy-
pothesis or research question to be tested. A thorough sys-
tematic review of the existing literature on the study aim
should form the basis of the decision whether to conduct
a certain study. Chalmers et al. [25] recommend that any
study proposal should include a systematic review of the
literature to justify the need for this new study. Researchers
should take into account what is already known about the
topic at issue, what their proposed research will add, and
to what societal expense this new knowledge can be gener-
ated. If evidence is sparse such an approach can be too so-
phisticated, but the study group should convince itself that
they have a good understanding of the available evidence.
Researchers should start documenting their work from
this phase onward, so they can later disclose how they have
derived their definitive research question.4.3. Designing a research grant proposal and the study
protocol
Every epidemiologic study, with the aim of publishing the
results should be based on a detailed study protocol. The
level of detail should be such that another study group would
be able to carry out the study as intended with the protocol in
hand. It is the responsibility of the entire study group to pro-
duce the research grant proposal and the study protocol.A grant proposal can serve as study protocol if it has the
necessary level of detail required for a study protocol.
Grant proposals are intended to obtain the necessary re-
sources for a study and may not yet describe the planned
study in all its relevant details and finesse. In that case,
the study group will have to prepare a detailed study
protocol before starting the study as soon as funding is
obtained.
The study group should ensure that adequate research
methods are used. These methods should meet the stan-
dards of the research field. Research using suboptimal
research methods is considered unethical and adds to the
body of research waste. Before the study group starts con-
ducting the study, a protocol should be written and agreed
on. Ideally, the protocol contains a description of the
research design, justification of the study population and
sample size, a data management plan with quality assur-
ance and auditing steps, and the statistical analysis plan.
It should also contain a list of envisioned publications
and authors who will contribute to each publication. It is
strongly recommended that the study protocol is made pub-
lic, either by placing it on a publicly accessible website or
by uploading it in an appropriate studies register. Prepubli-
cation of the protocol strongly enhances transparency and
future accountability. There might be occasions where the
study group decides not to disclose a study protocol before
publication of the study results, for example, the develop-
ment of a new drug or medical treatment or innovative dis-
covery. In such cases, a copy of the protocol should be
deposited in a suitable registry without making it publicly
accessible that will treat it as confidential until the study
is completed, for example, a notary. Then, once the study
is completed, the deposited copy can be disclosed.4.4. Submitting a grant proposal and accepting
financial support
The entire study group is responsible and accountable
for the contents of the grant proposal, and no promises
should be made to the funding agency or sponsor that will
be difficult to keep, without mentioning this. Members of
the study group should not be involved in the review of
the grant proposal. In addition, members of the study group
should disclose at this stage any other sources of funding
received and all conflicts of interest that may collide with
the funding sought.
On the other hand, the study group should only accept
funding if an independent execution of the entire study,
including full disclosure of the results, without any interfer-
ence of the sponsor is guaranteed. No publication vetoes are
acceptable, and stopping rules should be formulated care-
fully. It is acceptable that the sponsor may claim the right
to see the results before disclosure and have a reasonable
embargo period, but it should not be in the position to un-
reasonably delay or block publication or influence how the
results are disclosed.
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Epidemiologic studies involving human subjects are
required to be reviewed by an appropriate ethical review
committee. Ethical review must be successfully completed
before the start of data collection. In most Western coun-
tries, all intervention studies on human subjects must be re-
viewed by a certified ethical committee. Observational
studies on humans may not necessarily be reviewed by an
ethical committee, but we recommend the study group to
verify the need for review with the ethical review commit-
tee. In the case review is not necessary, a waiver must be
obtained.5. Conducting the study
The epidemiologic study should be carried out in accor-
dance with the study protocol. Protocol deviations should
be recorded and reported with the reasons why these were
deemed necessary. Alternatively, the protocol can be
amended, but these amendments must be clearly
identifiable.
5.1. Human volunteers’ protection
In case the epidemiology study includes human volun-
teers, the internationally accepted guidelines should be fol-
lowed (see e.g., the Declaration of Helsinki [26]). Human
volunteers should be well informed about the study and
about what is asked from them and should all sign an
informed consent form that is archived in the study records.
Risks and burdens should be clearly explained and should
be acceptable and proportional to the potential benefits of
the study. Human volunteers should be treated with respect,
and their privacy should be well guarded. Human volun-
teers are protected by law, and the pertinent regulations
must be adhered to.
5.2. Data collection
The data collection phase should also be carried out in
accordance with the protocol. Protocol deviations should
be documented, reported, and motivated. Quality checks
and checks for completeness should be included. Data sets
should be checked for accuracy by means of manual checks
and by running frequency tables and cross tabulations to
identify errors. Copies should be stored in secure places.
The data collection process is a vital element of any study
and therefore should be documented in detail. A digital log,
analogous to the lab journal in laboratories, should be a part
of this documentation process.
5.3. Statistical analysis
Before the statistical analysis, the raw data set should be
finalized. No changes to the raw data set should be made
once the statistical analysis has started. Again, thestatistical analysis should be conducted according to the
protocol. Often, additional analyses will be conducted that
were not foreseen at the time of protocol development.
These should be clearly explained in the report. Journal re-
viewers may request additional analyses. As these were
obviously not foreseen in the study protocol, it must be
mentioned in the publication.
Protocol adherence should not be so rigorous that the
data are not optimally analyzed. Both unplanned and
planned but not conducted analyses should be reported
and motivated.
The syntax files of all conducted analyses should be stored
as key document and archived and preferably made public.
5.4. Preparing report(s)
Preparation of the report is a responsibility of the entire
study group. The report must be an accurate, balanced, and
concise reflection of the conducted study, taking into ac-
count existing reporting guidelines, and it should describe
its limitations and any deviations from the protocol. The
report can be in the form of one or more scientific publica-
tions. Explorative analyses must be identified as such in the
publications.6. Dissemination and archiving
A scientific study is only completed when all its results
are properly reported and disclosed and when the study has
been well documented and archived. Documentation and
archiving should be done in such a way that a trained sci-
entist, not necessarily an epidemiologist, can reconstruct
how the study was conducted. Ideally, the report(s) must
fully document the conducted study, but in most cases, it
will not contain every detail of the study. Therefore, all
epidemiologic research with the aim of publishing it should
be based on a detailed study protocol. Caution should be
taken in publishing results from nonprotocolized research
to avoid publication bias and outcome reporting bias. As
an exception, nonprotocoled research can be published un-
der the condition that this is clearly stated in the publica-
tion. In addition, explorative research, in which multiple
analyses are conducted, is regarded as publishable, under
the condition that this is clearly stated in the methods sec-
tion and clearly pointed out in the discussion section and
abstract.
6.1. Manuscript submission and reporting
Editorial instructions must be followed when submitting
a manuscript for publication. Conflicts of interest must al-
ways be disclosed in the publication.
There is no objection to writing multiple manuscripts
about a study as long as the content is distinctively
different, and this is not aimed at merely publishing as
many reports as possible. If the multitude of results requires
Table 1. List of deliverables per study element
Study element Deliverable
1a. The study group Minutes of the relevant meetings
1b. Meaningful research
question





Copy of protocol and/or grant
application, with sufficient
details to enable a trained
scientist to reconstruct the
entire study
1d. Grant submission Agreement with funding agency
and terms of conditions




Informed consent and informed
patient information
2b. Data collection Raw database, code book, and
data collection log
2c. Statistical analysis Syntax and program files
2d. Report preparation Final report, as intended for
submission to contractor and or





3b. Contacts with media Press release or similar documents
and the media coverage
3c. Data archiving and sharing Documents and agreements with
third parties who obtained
access to the data
3d. Document archiving Index of archived documents and
files
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cross-referenced so readers are aware of the other publica-
tions. The contributions to the manuscript of all authors
must be as described in the protocol.
Any protocolized study must be published. In the unlikely
situation that no scientific journal is willing to accept the
manuscript, it should be disclosed at the website of the
responsible institution or the register where the study was
preregistered or in any other form that is publicly accessible.
In case of a study remaining unpublished, it is very important
to document the trail of manuscript submissions and other
circumstantial reasons for not publishing the results.
6.2. Contact with media
Contacts with journalists are an optional part of the
dissemination process, after the reviewed manuscript has
been accepted for publication and preferably published.
The study and its results should be presented to journalists
in a reliable and balanced manner, without making the re-
sults appear to be more (or less) spectacular than they really
are. Authors should take efforts to ensure that the text to be
published in the journalistic product is accurate, precise,
correct, and understandable for the readers.
6.3. Data archiving and data sharing
Once the report is in a final form, the study group must
ensure that the raw data files and the final data set used for
the statistical analysis are securely stored, protecting pri-
vacy of subjects and be accompanied by a fully explanatory
data description or code book.
Data sharing is encouraged and should be the norm
because reuse of data makes research more useful and cost
effective. However, this secondary use should be in accor-
dance with the guideline for Responsible Epidemiologic
Research Practice.
Most sponsors do not specify ownership of the data. In
that case, the study group must consider itself (or more
formally the institution) the owner of the data, with all
the benefits but also all the responsibilities of good owner-
ship. If a sponsor insists on being the owner, the study
group must consider refraining from accepting the grant
if external ownership is deemed incompatible with the stan-
dards of the study group. Research data should only be
shared for reuse if the secondary analyses are compatible
with the approval obtained from the ethical review commit-
tee. In case of doubt, this committee should be asked to re-
view the request for data sharing. In this respect, we refer to
findable, accessible, interoperable, and reusable guiding
principles for scientific data management and stewardship
(https://www.ncbi.nlm.nih.gov/pubmed/26978244).
6.4. Document archiving
A study consists of more documents than the protocol,
the data set, statistical analysis, syntax, results, and finalreport(s). For transparency and accountability reasons, it
is recommended that other documents, such as question-
naires, meeting minutes, conference presentations, interim
reports, and so forth are also stored for future reference.
As example of a storage facility, we refer the reader to
‘‘Dataverse’’, which has been set up by an international
community of academic institutions to store data sets, syn-
taxes, and so forth [27]. This facility is access controlled.
Researchers can choose the level of access preferred.
Another example is data archiving and network services,
the Dutch network of data storage for academic institutions.
Which documents should be archived? As a general rule,
archiving should be such that a well-trained scientist, not
necessarily an epidemiologist, will be able to reconstruct
in detail how the study was conducted and also be able to
repeat the study. The archive must also contain all relevant
details for an investigation or an audit that may be re-
quested by a scientific journal or a committee, investigating
an allegation of a breach of research integrity. Table 1 con-
tains the key products or ‘‘deliverables’’ produced in the
earlier described elements of the epidemiologic study that
should be stored in the study archive. Ideally, this archive
117G.M.H. Swaen et al. / Journal of Clinical Epidemiology 100 (2018) 111e119is publicly accessible on a website or in a registry or
repository.
6.5. Accountability and transparency
Throughout the study execution, but also after the study
has been finalized, the study group is accountable for its
work. Requests from third parties to explain and elucidate
the study should be taken seriously andewithin reason-
ecomplied to. The task of being a corresponding author
of a publication comes with the responsibility to answer
questions from interested parties, within a certain limit of
reason. Issues arising from the conduct of the study, in
which the study group is held accountable should also be
dealt with accordingly. Accountability of study group mem-
bers is not restricted to their own individual contribution. It
encompasses the contributions of the other members as
well. In case of concern about research misconduct or detri-
mental research practices by a member of the study group,
or as a whole proper action should be taken, for example,
by discussing this with the entire study group or even by re-
porting this to the appropriate Research Integrity Authority.7. Discussion
Responsible conduct of research and scientific integrity
are topics that are receiving increasing attention in the lay
press as well as in the scientific literature. The
Netherlands Epidemiological Society has developed the
RERP guideline with the aim to make our membership
and other researchers better aware of the key issues. We
hope epidemiologists and scientists in other disciplines
will embrace our guideline and start using it in their
day-to-day work. We realize that implementation of these
guidelines will cost some effort, both to convince col-
leagues of the need as well as to set up the infrastructure
and training to adhere to these guidelines. Following the
guideline during the conduct of an epidemiologic study
will lead to some additional administrative burden on
the part of the study group. However, there are also
short-term benefits from a sound documentation and
archiving process. A detailed protocol for example will
avoid many discussions about the study methods during
its actual conduct. It will assist the authors in writing their
journal articles, and it will facilitate explaining why
certain decisions have been made. Furthermore, it will
avoid the painful discussions about authorship, roles to
be performed during the conduct of the study because they
have been defined and documented at an early stage. It
would be helpful if a software program can be developed
that assists the study group during the conduct of the study
and provides reminders and solutions for all the elements
and steps involved. Some research institutes already have
software in place intended to aid researchers with their
projects. At the preconference several were mentioned:
Some institutes like Netherlands Institute for HealthServices Research have developed standard operating pro-
cedures to be followed for research following specific de-
signs. They also developed an ISO-certified quality
management system covering all aspects of conducted
research. Several universities or university departments
(Groningen and Nijmegen) have software in place where
critical documents of studies can be deposited.
The Responsible Epidemiologic Research Practice
guideline recommends that every scientist should have
mastered in his/her basic training, but it also includes rec-
ommendations that are fairly new. For example, it is a basic
philosophy of science that any scientific endeavor must be
based on a testable hypothesis that can be verified or falsi-
fied. On the other hand, the recommendation that any study
should be based on a detailed protocol accessible to others
and the recommendation that the results of any protocoled
study must be published are fairly new insights.
RERP should not result in a box ticking exercise. It
should genuinely assist the study group in documenting
and archiving the study and thus will increase transparency
and accountability. Furthermore, RERP should not be
considered the single solution to detrimental research prac-
tices. More is needed, especially concerning cultural
change in research institutions and among scientists, with
less focus on output quantity, impact factors, and career
development but more on responsible research conduct. Ep-
idemiologists should be more open and honest about their
research. They should welcome scrutiny and critical re-
marks from their peers. We strongly believe that the basis
of this cultural change lies in educating epidemiologists
and also by implementing RERP in the curriculum of
epidemiology courses. Merely drafting a guideline on
responsible conduct of epidemiologic research will prob-
ably not have a substantial impact on itself. It must be seen
as a part of an already ongoing process toward more aware-
ness about responsible research conduct. The Netherlands
Epidemiological Society has put an implementation plan
in place aimed at further dissemination and implementation
of RERP in the Dutch epidemiology community and
beyond. So far, members of the RERP working group have
made five presentations to epidemiological research groups
in the country. We aim at expanding these visits and plan to
come back to these groups after 1 or 2 years to see what has
been implemented. Training in research integrity as a
whole, but also in the more practical issues as described
in RERP, should become an integral part of scientific edu-
cation, preferably starting at an early stage in the curricu-
lum. Scientists might be reluctant to take time or spend
resources for responsible conduct of research [28], but they
should realize that a good documentation process for their
work already has short-term advantages and certainly will
pay off when writing journal articles. Thoroughly thinking
through the entire research project before starting and
writing it down in the form of a study protocol will avoid
unanticipated issues when conducting it and will provide
an opportunity to solve these issues at a stage when it is still
118 G.M.H. Swaen et al. / Journal of Clinical Epidemiology 100 (2018) 111e119possible to do so. In addition, the Responsible Epidemio-
logic Research Practice guideline will probably have a mi-
nor effect, if any, of reducing research misconduct in the
form of fabrication, falsification, or plagiarism. Scientists
willing to fabricate data are likely to be willing to fabricate
documents mentioned in the guideline as well. The main
aim of the guideline is to reduce detrimental research prac-
tices, which are more frequent and as a whole have a larger
impact than research misconduct.
The main responsibility of implementing and enforcing
the guideline does not lie with the Netherlands Epidemio-
logical Society but rather with the individual epidemiolo-
gist, the department he/she works in and ultimately with
the employer. One should realize that detrimental research
practices or research misconduct by one individual epide-
miologist can adversely impact the reputation of the institu-
tion and eventually to the epidemiology community as a
whole. This also applies to the funding agency or sponsor.
Sponsors are encouraged to more closely follow and audit
projects that receive funding. They have an obligation to
ensure that the funding is well spent and that the study is
conducted according to the funded project proposal. TheTable 2. Set of recommendations
Study element
1a. The study group The first step in any epidem
accountabilities of its me
1b. Meaningful research question The first task of the study g
tested. Include a system
1c. Research protocol/grant proposal Every epidemiologic study,
research protocol describ
able to carry out the stud
Once finalized, it is require
on a publicly accessible
1d. Grant submission Be frank about your projec
1e. Ethical review Review by appropriate com
2a. Human volunteers protection The conduct of the epidem
protocol and by adhering
2b. Data collection The data collection process
detail. Include a digital l
2c. Statistical analysis The statistical analysis sho
2d. Report preparation The report must be an accu
account existing guidelin
protocol
3a. Manuscript submission A scientific study is only co
has been well document
Any protocoled study must
3b. Contacts with journalists The study and its results sh
without making the resul
3c. Data archiving and sharing Once the report is in a final
data set used for the stat
accompanied by a fully e
Data sharing in principle is
research more cost-effec
3d. Document archiving Throughout the study execu
accountable for its work.Netherlands Epidemiological Society welcomes recent re-
quirements of several Dutch funding agencies that require
researchers to use data management software to ensure
quality and documentation. Other stakeholders might also
benefit from the guideline. Journal editors may request a
statement that the study was conducted following the
guideline, and ultimately the reader would have more con-
fidence in the journal article if the authors state it was con-
ducted according to the guideline. The guideline is a first
step but not the final one toward enhancing responsible
research practice. It can be expected that future develop-
ments will require the Netherlands Epidemiological Society
to update this document and further develop its contents.
The guideline requires more extensive documentation and
archiving than before. Some documents are strongly recom-
mended to be disclosed on the internet before data collec-
tion, including the study protocol. Researchers should be
aware that due to this improved documentation and disclo-
sure, the privacy of study participants can become compro-
mised. Sharing data is a virtue, but researchers must be
aware of the importance to protect the privacy of the study
participants. Principally, data sharing is seen as aRecommendation
iologic study is to establish a study group and the responsibilities and
mbers.
roup is to define the aim of the study or specific hypothesis to be
atic review of the literature if applicable
with the aim of publishing the results, should be based on a detailed
ing the study. The level of detail is such that another research group is
y as intended with the protocol in hand.
d that the study protocol is ultimately made public, either by placing it
website or by uploading it in an appropriate studies register
t and do not promise more than you can deliver
mittee
iologic study should be carried out in accordance with the study
to the Declaration of Helsinki
is a vital element of any study and therefore should be documented in
og
uld be conducted according to the protocol.
rate balanced and concise reflection of the conducted study taking into
es, and it should describe its limitations and deviations from the
mpleted when all its results are properly reported and when the study
ed and archived
be published
ould be presented to journalists in a reliable and balanced manner,
ts appear to be more (or less) than they really are.
form, the study group must ensure that the raw data files and the final
istical analysis are securely stored, protecting privacy of subjects and
xplanatory data description or code book.
encouraged and should be the norm because reuse of data makes
tive.
tion, but also after the study has been finalized, and the study group is
119G.M.H. Swaen et al. / Journal of Clinical Epidemiology 100 (2018) 111e119responsible practice because it makes better use of the
limited resources. However, also data sharing is not without
responsibility. The data provider should ensure that the data
are used properly and that the data receiver understands the
data and uses it in a scientifically responsible way. Co-
authorship also comes with the responsibility to ensure
proper data use and interpretation.
The results of epidemiologic research should preferably be
available to all. Therefore, open access publishing is sup-
ported. However, it should not be at the expense of the peer re-
view process. Certain open access journals can increase their
profits by publishing asmanymanuscripts as possible and take
peer review less serious. This will have a negative impact on
the quality of the published articles. In the long run, we are
convinced that the guideline will demonstrate its merits by
means of creating a more transparent and better documented
process. While developing the guideline, we received many
helpful comments from our members. Two suggestions stand
out. First, an e-learningmodulewould be illustrative and assist
epidemiologists tounderstand theguideline. Second, an IT tool
should be developed that assists epidemiologists in their daily
work inRERP compliance. In conclusion, we have formulated
a set of recommendations to our members, which have been
taken from our document and are displayed in Table 2.References
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